Role of HIV-specific CD8+ T cells in pediatric HIV cure strategies after widespread early viral escape
暂无分享,去创建一个
B. Walker | O. Pybus | T. Ndung’u | P. Goulder | P. Kellam | J. Hemelaar | P. Kiepiela | J. Raghwani | V. Naranbhai | M. Ansari | A. Gall | M. Mori | C. Thobakgale | P. Matthews | M. Tsai | A. Prendergast | G. Tudor-Williams | G. Luzzi | E. Adland | E. Leitman | L. Riddell | Pieter Jooste | J. Brener | Tsai M-H. | Goulder Pjr. | Jacqui Brener
[1] J. Church. Nonprogressing HIV-Infected Children Share Fundamental Immunological Features of Nonpathogenic SIV Infection , 2017, Pediatrics.
[2] B. Walker,et al. Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection , 2016, Science Translational Medicine.
[3] T. Ndung’u,et al. Paediatric non-progression following grandmother-to-child HIV transmission , 2016, Retrovirology.
[4] A. Folgori,et al. Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection , 2016, Vaccines.
[5] Barton F. Haynes,et al. Latency reversal and viral clearance to cure HIV-1 , 2016, Science.
[6] B. Walker,et al. Relative rate and location of intra-host HIV evolution to evade cellular immunity are predictable , 2016, Nature Communications.
[7] Charles E. DeZiel,et al. Impact of Pre-adapted HIV Transmission , 2016, Nature Medicine.
[8] A. McMichael,et al. Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.
[9] S. Lewin,et al. Paediatric HIV infection: the potential for cure , 2016, Nature Reviews Immunology.
[10] B. Walker,et al. Lower Viral Loads and Slower CD4+ T-Cell Count Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02 , 2016, Journal of Infectious Diseases.
[11] R. Siliciano,et al. HIV-specific CD8⁺ T cells and HIV eradication. , 2016, The Journal of clinical investigation.
[12] C. Rouzioux,et al. HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report. , 2016, The lancet. HIV.
[13] M. Carrington,et al. Discordant Impact of HLA on Viral Replicative Capacity and Disease Progression in Pediatric and Adult HIV Infection , 2015, PLoS pathogens.
[14] Astrid Gall,et al. IVA: accurate de novo assembly of RNA virus genomes , 2015, Bioinform..
[15] R. Siliciano,et al. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations , 2015, Nature.
[16] Angela R. McLean,et al. Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence , 2014, Proceedings of the National Academy of Sciences.
[17] P. Klenerman,et al. Programmed death-1 expression on HIV-1-specific CD8+ T cells is shaped by epitope specificity, T-cell receptor clonotype usage and antigen load , 2014, AIDS.
[18] T. Hanke,et al. Safety and Tolerability of Conserved Region Vaccines Vectored by Plasmid DNA, Simian Adenovirus and Modified Vaccinia Virus Ankara Administered to Human Immunodeficiency Virus Type 1-Uninfected Adults in a Randomized, Single-Blind Phase I Trial , 2014, PloS one.
[19] B. Walker,et al. HIV subtype influences HLA-B*07:02-associated HIV disease outcome. , 2014, AIDS research and human retroviruses.
[20] P. Kellam,et al. Complete Genome Sequence of the WHO International Standard for HIV-1 RNA Determined by Deep Sequencing , 2014, Genome Announcements.
[21] Jessica Prince,et al. Selection bias at the heterosexual HIV-1 transmission bottleneck , 2013, Science.
[22] Gabor T. Marth,et al. MOSAIK: A Hash-Based Algorithm for Accurate Next-Generation Sequencing Short-Read Mapping , 2013, PloS one.
[23] Koichiro Tamura,et al. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. , 2013, Molecular biology and evolution.
[24] D. Richman,et al. Absence of detectable HIV-1 viremia after treatment cessation in an infant. , 2013, The New England journal of medicine.
[25] N. Frahm,et al. Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection. , 2013, The Journal of infectious diseases.
[26] B. Walker,et al. HLA-A*68: 02-restricted Gag-specific cytotoxic T lymphocyte responses can drive selection pressure on HIV but are subdominant and ineffective , 2013, AIDS.
[27] B. Angus,et al. Improved quantification of HIV-1-infected CD4+ T cells using an optimised method of intracellular HIV-1 gag p24 antigen detection. , 2013, Journal of immunological methods.
[28] Brigitte Autran,et al. Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study , 2013, PLoS pathogens.
[29] Andrew L. Ferguson,et al. Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design. , 2013, Immunity.
[30] David Heckerman,et al. Frequent and Variable Cytotoxic-T-Lymphocyte Escape-Associated Fitness Costs in the Human Immunodeficiency Virus Type 1 Subtype B Gag Proteins , 2013, Journal of Virology.
[31] Feng Gao,et al. Vertical T cell immunodominance and epitope entropy determine HIV-1 escape. , 2012, The Journal of clinical investigation.
[32] Anuska Llano,et al. Best-Characterized HIV-1 CTL Epitopes: The 2013 Update , 2013 .
[33] B. Walker,et al. HIV and HLA class I: an evolving relationship. , 2012, Immunity.
[34] Astrid Gall,et al. Universal Amplification, Next-Generation Sequencing, and Assembly of HIV-1 Genomes , 2012, Journal of Clinical Microbiology.
[35] Andrew K. Sewell,et al. Differential Clade-Specific HLA-B*3501 Association with HIV-1 Disease Outcome Is Linked to Immunogenicity of a Single Gag Epitope , 2012, Journal of Virology.
[36] B. Walker,et al. HIV control through a single nucleotide on the HLA-I locus , 2012, Retrovirology.
[37] S. Deeks. HIV: Shock and kill , 2012, Nature.
[38] Huldrych F. Günthard,et al. Whole Genome Deep Sequencing of HIV-1 Reveals the Impact of Early Minor Variants Upon Immune Recognition During Acute Infection , 2012, PLoS pathogens.
[39] David Heckerman,et al. Correlates of Protective Cellular Immunity Revealed by Analysis of Population-Level Immune Escape Pathways in HIV-1 , 2012, Journal of Virology.
[40] Zabrina L. Brumme,et al. Impact of HLA-B*81-Associated Mutations in HIV-1 Gag on Viral Replication Capacity , 2012, Journal of Virology.
[41] Michael A Quail,et al. Optimal enzymes for amplifying sequencing libraries , 2011, Nature Methods.
[42] B. Walker,et al. HLA-B*57 Micropolymorphism Shapes HLA Allele-Specific Epitope Immunogenicity, Selection Pressure, and HIV Immune Control , 2011, Journal of Virology.
[43] J. Brenchley,et al. Low levels of SIV infection in sooty mangabey central-memory CD4+ T-cells is associated with limited CCR5 expression , 2011, Nature Medicine.
[44] D. Heckerman,et al. HLA-A*7401–Mediated Control of HIV Viremia Is Independent of Its Linkage Disequilibrium with HLA-B*5703 , 2011, The Journal of Immunology.
[45] J. Kappes,et al. An HIV-1 gp120 Envelope Human Monoclonal Antibody That Recognizes a C1 Conformational Epitope Mediates Potent Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity and Defines a Common ADCC Epitope in Human HIV-1 Serum , 2011, Journal of Virology.
[46] David Heckerman,et al. Gag-Protease-Mediated Replication Capacity in HIV-1 Subtype C Chronic Infection: Associations with HLA Type and Clinical Parameters , 2010, Journal of Virology.
[47] S. Buus,et al. Efficacious Early Antiviral Activity of HIV Gag- and Pol-Specific HLA-B*2705-Restricted CD8+ T Cells , 2010, Journal of Virology.
[48] P. Goulder,et al. Long-Term Control of HIV-1 in Hemophiliacs Carrying Slow-Progressing Allele HLA-B*5101 , 2010, Journal of Virology.
[49] Bette Korber,et al. Mosaic HIV-1 Vaccines Expand the Breadth and Depth of Cellular Immune Responses in Rhesus Monkeys , 2010, Nature Medicine.
[50] B. Walker,et al. Impact of HLA in Mother and Child on Disease Progression of Pediatric Human Immunodeficiency Virus Type 1 Infection , 2009, Journal of Virology.
[51] B. Autran,et al. Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. , 2009, Blood.
[52] Alan S. Perelson,et al. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection , 2009, The Journal of experimental medicine.
[53] Todd M. Allen,et al. HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphocyte Recognition , 2009, Journal of Virology.
[54] David Heckerman,et al. Adaptation of HIV-1 to human leukocyte antigen class I , 2009, Nature.
[55] Eric J. Arts,et al. Variable Fitness Impact of HIV-1 Escape Mutations to Cytotoxic T Lymphocyte (CTL) Response , 2009, PLoS pathogens.
[56] Paediatric European Network for Treatment of AIDS , 2009 .
[57] Bin Li,et al. HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition , 2008, Journal of Virology.
[58] Richard Durbin,et al. A large genome center's improvements to the Illumina sequencing system , 2008, Nature Methods.
[59] A. d’Arminio Monforte,et al. Response to combination antiretroviral therapy: variation by age , 2008, AIDS.
[60] B. Walker,et al. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants , 2008, AIDS.
[61] David Heckerman,et al. Marked Epitope- and Allele-Specific Differences in Rates of Mutation in Human Immunodeficiency Type 1 (HIV-1) Gag, Pol, and Nef Cytotoxic T-Lymphocyte Epitopes in Acute/Early HIV-1 Infection , 2008, Journal of Virology.
[62] D. Heckerman,et al. Central Role of Reverting Mutations in HLA Associations with Human Immunodeficiency Virus Set Point , 2008, Journal of Virology.
[63] David Heckerman,et al. Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients , 2008, The Journal of experimental medicine.
[64] Todd M. Allen,et al. Crippling HIV one mutation at a time , 2008, The Journal of experimental medicine.
[65] D. Heckerman,et al. Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure. , 2008, AIDS research and human retroviruses.
[66] N. Jones,et al. Profile of T cell immune responses in HIV-infected children from Uganda. , 2007, The Journal of infectious diseases.
[67] David A. Price,et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover , 2007, The Journal of experimental medicine.
[68] B. Walker,et al. Human Immunodeficiency Virus-Specific CD8+ T-Cell Activity Is Detectable from Birth in the Majority of In Utero-Infected Infants , 2007, Journal of Virology.
[69] D. Watkins,et al. Pol-Specific CD8+ T Cells Recognize Simian Immunodeficiency Virus-Infected Cells Prior to Nef-Mediated Major Histocompatibility Complex Class I Downregulation , 2007, Journal of Virology.
[70] B. Walker,et al. High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis , 2007, AIDS.
[71] E. Rosenberg,et al. Recognition of a Defined Region within p24 Gag by CD8+ T Cells during Primary Human Immunodeficiency Virus Type 1 Infection in Individuals Expressing Protective HLA Class I Alleles , 2007, Journal of Virology.
[72] D. Watkins,et al. Gag-Specific CD8+ T Lymphocytes Recognize Infected Cells before AIDS-Virus Integration and Viral Protein Expression1 , 2007, The Journal of Immunology.
[73] David Heckerman,et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load , 2007, Nature Medicine.
[74] James Theiler,et al. Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants , 2007, Nature Medicine.
[75] M. Hoelscher,et al. CD8 T-Cell Recognition of Multiple Epitopes within Specific Gag Regions Is Associated with Maintenance of a Low Steady-State Viremia in Human Immunodeficiency Virus Type 1-Seropositive Patients , 2006, Journal of Virology.
[76] B. Walker,et al. Differential selection pressure exerted on HIV by CTL targeting identical epitopes but restricted by distinct HLA alleles from the same HLA supertype , 2006, The Journal of Immunology.
[77] Todd M. Allen,et al. Hitting HIV where it hurts: an alternative approach to HIV vaccine design. , 2006, Trends in immunology.
[78] Todd M. Allen,et al. HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8+ T Cell Response against HIV-1 , 2006, PLoS medicine.
[79] B. Walker,et al. Motif Inference Reveals Optimal CTL Epitopes Presented by HLA Class I Alleles Highly Prevalent in Southern Africa1 , 2006, The Journal of Immunology.
[80] B. Walker,et al. Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1 , 2006, Journal of Virology.
[81] Bette T. Korber,et al. Relative Dominance of Gag p24-Specific Cytotoxic T Lymphocytes Is Associated with Human Immunodeficiency Virus Control , 2006, Journal of Virology.
[82] K. Luzuriaga,et al. HIV-1-Specific CD8+ T Cell Responses and Viral Evolution in Women and Infants1 , 2005, The Journal of Immunology.
[83] Galit Alter,et al. De Novo Generation of Escape Variant-Specific CD8+ T-Cell Responses following Cytotoxic T-Lymphocyte Escape in Chronic Human Immunodeficiency Virus Type 1 Infection , 2005, Journal of Virology.
[84] C. Rouzioux,et al. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[85] Tulio de Oliveira,et al. An automated genotyping system for analysis of HIV-1 and other microbial sequences , 2005, Bioinform..
[86] E. Holmes,et al. Unique Acquisition of Cytotoxic T-Lymphocyte Escape Mutants in Infant Human Immunodeficiency Virus Type 1 Infection , 2005, Journal of Virology.
[87] Philip J. R. Goulder,et al. HIV-1 Viral Escape in Infancy Followed by Emergence of a Variant-Specific CTL Response1 , 2005, The Journal of Immunology.
[88] E. Handelsman,et al. Predictors of immunologic long-term nonprogression in HIV-infected children: implications for initiating therapy. , 2005, The Journal of allergy and clinical immunology.
[89] Bette Korber,et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA , 2004, Nature.
[90] A. Walker,et al. Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study , 2004, AIDS.
[91] D. Katzenstein,et al. Hierarchical Targeting of Subtype C Human Immunodeficiency Virus Type 1 Proteins by CD8+ T Cells: Correlation with Viral Load , 2004, Journal of Virology.
[92] Robert C. Edgar,et al. MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.
[93] Todd M. Allen,et al. HIV evolution: CTL escape mutation and reversion after transmission , 2004, Nature Medicine.
[94] E. Ulvestad,et al. Population-Based Hematologic and Immunologic Reference Values for a Healthy Ugandan Population , 2004, Clinical Diagnostic Laboratory Immunology.
[95] B. Walker,et al. Reconstitution of Virus-Specific CD4 Proliferative Responses in Pediatric HIV-1 Infection 1 , 2003, The Journal of Immunology.
[96] R. Koup,et al. T cell dynamics in HIV-1 infection. , 2003, Annual review of immunology.
[97] R. Gelman,et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. , 2003, The Journal of allergy and clinical immunology.
[98] Kristin Beaudry,et al. Viral Escape from Dominant Simian Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes in DNA-Vaccinated Rhesus Monkeys , 2003, Journal of Virology.
[99] Tao Dong,et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever , 2003, Nature Medicine.
[100] Martin A. Nowak,et al. Antibody neutralization and escape by HIV-1 , 2003, Nature.
[101] D. Strick,et al. Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load , 2003, Journal of Virology.
[102] T. Ndung’u,et al. Association between Virus-Specific T-Cell Responses and Plasma Viral Load in Human Immunodeficiency Virus Type 1 Subtype C Infection , 2003, Journal of Virology.
[103] Søren Brunak,et al. Clustering Patterns of Cytotoxic T-Lymphocyte Epitopes in Human Immunodeficiency Virus Type 1 (HIV-1) Proteins Reveal Imprints of Immune Evasion on HIV-1 Global Variation , 2002, Journal of Virology.
[104] M. Mulligan,et al. Magnitude of Functional CD8+ T-Cell Responses to the Gag Protein of Human Immunodeficiency Virus Type 1 Correlates Inversely with Viral Load in Plasma , 2002, Journal of Virology.
[105] Steven M. Wolinsky,et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes , 2002, Nature.
[106] R. Yogev,et al. Infrequent Detection of HIV-1-Specific, But Not Cytomegalovirus-Specific, CD8+ T Cell Responses in Young HIV-1-Infected Infants1 , 2001, The Journal of Immunology.
[107] Todd M. Allen,et al. Understanding cytotoxic T‐lymphocyte escape during simian immunodeficiency virus infection , 2001, Immunological reviews.
[108] Michael Bunce,et al. Evolution and transmission of stable CTL escape mutations in HIV infection , 2001, Nature.
[109] E. Rosenberg,et al. Rapid Definition of Five Novel HLA-A∗3002-Restricted Human Immunodeficiency Virus-Specific Cytotoxic T-Lymphocyte Epitopes by Elispot and Intracellular Cytokine Staining Assays , 2001, Journal of Virology.
[110] E. Rosenberg,et al. Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 Infection , 2001, The Journal of experimental medicine.
[111] E. Rosenberg,et al. Differential Narrow Focusing of Immunodominant Human Immunodeficiency Virus Gag-Specific Cytotoxic T-Lymphocyte Responses in Infected African and Caucasoid Adults and Children , 2000, Journal of Virology.
[112] N. Klein,et al. Immune repopulation after HAART in previously untreated HIV-1-infected children , 2000, The Lancet.
[113] Hiv Survival,et al. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis , 2000, The Lancet.
[114] M. Leal,et al. CD4+ and CD8+ T lymphocyte regeneration after anti‐retroviral therapy in HIV‐1‐infected children and adult patients , 2000, Clinical and experimental immunology.
[115] B. Walker,et al. The great escape – AIDS viruses and immune control , 1999, Nature Medicine.
[116] F. Roudot-thoraval,et al. Plasma human immunodeficiency virus RNA below 40 Copies/mL is rare in untreated persons even in the first years of infection. , 1999, The Journal of infectious diseases.
[117] F. Miedema,et al. T cell dynamics in HIV-1 infection. , 1999, Advances in immunology.
[118] Rolf M. Zinkernagel,et al. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes , 1998, Nature.
[119] L. Montagnier,et al. Simian Immunodeficiency Virus Replicates to High Levels in Sooty Mangabeys without Inducing Disease , 1998, Journal of Virology.
[120] M A Nowak,et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.
[121] R. Phillips,et al. Identification of a novel HLA-A24-restricted cytotoxic T-lymphocyte epitope within HIV-1 Nef. , 1997, AIDS.
[122] C. Rouzioux,et al. Morbidity and mortality in European children vertically infected by HIV-1. The French Pediatric HIV Infection Study Group and European Collaborative Study. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[123] P. Sansonetti,et al. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. , 1995, AIDS research and human retroviruses.
[124] H. Schuitemaker,et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics , 1995, The Journal of experimental medicine.
[125] J. Sullivan,et al. HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. , 1995, Journal of immunology.
[126] E. Abrams,et al. Paediatric HIV infection. , 1991, Bailliere's clinical haematology.